Expert Opinion on Drug Metabolism and Toxicology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
What is the significance of the pharmacokinetic profile and potential drug –drug interactions of long-acting intramuscular cabotegravir and rilpivirine?
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 13, 2023 Category: Drugs & Pharmacology Authors: Sara Bettonte Mattia Berton Catia Marzolini Source Type: research
Population pharmacokinetic –pharmacodynamic analysis of givinostat
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 12, 2023 Category: Drugs & Pharmacology Authors: Francesco Fiorentini Massimiliano Germani Francesca Del Bene Cinzia Pellizzoni Sara Cazzaniga Maurizio Rocchetti Paolo Bettica Source Type: research
The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 8, 2023 Category: Drugs & Pharmacology Authors: Merve Demirbugen Oz Fezile Ozdemir Kenan Can Tok Emrah Dural Yagmur Kir Muge Ulusoy Mehmet Gumustas Bora Baskak H. Sinan Suzen Source Type: research
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 8, 2023 Category: Drugs & Pharmacology Authors: Maria Gabriella Matera Paola Rogliani Giuseppe Novelli Mario Cazzola Source Type: research
Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 6, 2023 Category: Drugs & Pharmacology Authors: Eunjin Hong Alan Shi Paul Beringer Source Type: research
Probing the mechanism of reduced in vivo potency of insulin detemir
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 5, 2023 Category: Drugs & Pharmacology Authors: Christian Lehn Brand Jeppe Sturis Source Type: research
Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 2, 2023 Category: Drugs & Pharmacology Authors: Georgios Schoretsanitis Jonathan M. Meyer Andreas Conca Christoph Hiemke Source Type: research
Lessons learned from the influence of CYP2C9 genotype on warfarin dosing
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - June 2, 2023 Category: Drugs & Pharmacology Authors: Nicola Tidbury Joshua Preston Gregory Y.H. Lip Source Type: research
A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - May 30, 2023 Category: Drugs & Pharmacology Authors: Haiyan Yang Zheng Wan Moliang Chen Xiaohong Zhang Wugeng Cui Bin Zhao Source Type: research
Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 24, 2023 Category: Drugs & Pharmacology Authors: Mohitosh Biswas John Shobana Pimonpan Jinda Chonlaphat Sukasem Source Type: research
Drug-induced liver injury associated with the use of newer antiseizure medications in the elderly: an analysis of data from VigiBase
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 24, 2023 Category: Drugs & Pharmacology Authors: Sanja Petrovi ć Milena Kova čević Sandra Vezmar Kova čević Branislava Miljkovic Source Type: research
Genetic variation in organic cation transporters and considerations in drug development
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 24, 2023 Category: Drugs & Pharmacology Authors: Manthena V. S. Varma Source Type: research
Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 20, 2023 Category: Drugs & Pharmacology Authors: Teruo Murakami Erik Bodor Nicholas Bodor Source Type: research
Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 20, 2023 Category: Drugs & Pharmacology Authors: Teruo Murakami Erik Bodor Nicholas Bodor Source Type: research
What is the significance of the impact of antipsychotics on the gut microbiome?
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 10, 2023 Category: Drugs & Pharmacology Authors: Mary V. Seeman Source Type: research